Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease

References

• DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8:523-31; PMID:21844910; http://dx.doi.org/10.1038/nrgastro.2011.133
   PubMed Web of Science ®Google Scholar
• Packey C, Sartor R. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009; 22:292-301; PMID:19352175; http://dx.doi.org/10.1097/QCO.0b013e32832a8a5d
   PubMed Web of Science ®Google Scholar
• Suchodolski JS, Dowd SE, Wilke V, Steiner JM, Jergens AE. 16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease. PLoS One 2012; 7:e39333; PMID:22720094; http://dx.doi.org/10.1371/journal.pone.0039333
   PubMed Web of Science ®Google Scholar
• Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, Kachroo P, Ivanov I, Minamoto Y, Dillman EM, et al. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS One 2012; 7:e51907; PMID:23300577; http://dx.doi.org/10.1371/journal.pone.0051907
   PubMed Web of Science ®Google Scholar
• Suchodolski JS, Xenoulis PG, Paddock CG, Steiner JM, Jergens AE, Steiner JM. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Vet Microbiol 2010; 142:394-400; PMID:19959301; http://dx.doi.org/10.1016/j.vetmic.2009.11.002
   PubMed Web of Science ®Google Scholar
• Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 2008; 66:579-89; PMID:18647355; http://dx.doi.org/10.1111/j.1574-6941.2008.00556.x
   PubMed Web of Science ®Google Scholar
• Simpson KW, Jergens AE. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet Clin North Am Small Anim Pract 2011; 41:381-98; PMID:21486642; http://dx.doi.org/10.1016/j.cvsm.2011.02.003
   PubMed Web of Science ®Google Scholar
• Overstreet A, Ramer-Tait A. The Role of the Microbiota in Gastrointestinal Health and Disease. In: Szabo I, editor. Inflammatory Bowel Disease. InTech Published; 2012
   Google Scholar
• Washabau R, Day M. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med 2010; 24:10-26; PMID:20391635; http://dx.doi.org/10.1111/j.1939-1676.2010.0520.x
   PubMed Web of Science ®Google Scholar
• Jergens a E, Crandell J, Morrison J a, Deitz K, Pressel M, Ackermann M, Suchodolski JS, Steiner JM, Evans R. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med 2010; 24:269-77; PMID:20051005; http://dx.doi.org/10.1111/j.1939-1676.2009.0447.x
   PubMed Web of Science ®Google Scholar
• Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013; 14:676-84; PMID:23778795; http://dx.doi.org/10.1038/ni.2640
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455:1054-6; PMID:18948945; http://dx.doi.org/10.1038/4551054a
   PubMedGoogle Scholar
• Marchesi J, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson I, Wang Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6:546-51; PMID:17269711; http://dx.doi.org/10.1021/pr060470d
   PubMed Web of Science ®Google Scholar
• Lin H-M, Helsby N, Rowan D, Ferguson L. Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:1021-9; PMID:20629098; http://dx.doi.org/10.1002/ibd.21426
   PubMed Web of Science ®Google Scholar
• De Preter V, Verbeke K. Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther 2013; 4:97-107; PMID:24199025
   PubMedGoogle Scholar
• Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012; 13:263-9; PMID:22436749; http://dx.doi.org/10.1038/nrm3314
   PubMed Web of Science ®Google Scholar
• Steelman SM, Johnson P, Jackson A, Schulze J, Chowdhary BP. Serum metabolomics identifies citrulline as a predictor of adverse outcomes in an equine model of gut-derived sepsis. Physiol Genomics 2014; 46:339-47; PMID:24619519; http://dx.doi.org/10.1152/physiolgenomics.00180.2013
   PubMed Web of Science ®Google Scholar
• Zhang J, Wei S, Liu L, Nagana Gowda G a, Bonney P, Stewart J, Knapp DW, Raftery D. NMR-based metabolomics study of canine bladder cancer. Biochim Biophys Acta 2012; 1822:1807-14; PMID:22967815; http://dx.doi.org/10.1016/j.bbadis.2012.08.001
   PubMed Web of Science ®Google Scholar
• Ritchie L, Burke K, Garcia-Mazcorro J, Steiner J, Suchodolski J. Characterization of fecal microbiota in cats using universal 16S rRNA gene and group-specific primers for Lactobacillus and Bifidobacterium spp. Vet Microbiol 2010; 144:140-146; PMID:20092970; http://dx.doi.org/10.1016/j.vetmic.2009.12.045
   PubMedGoogle Scholar
• Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol 201; 76:301-10; http://dx.doi.org/10.1111/j.1574-6941.2011.01058.x
   Google Scholar
• Ritchie L, Steiner J, Suchodolski J. Assessment of microbial diversity along the feline intestinal tract using 16S rRNA gene analysis. FEMS Microbiol Ecol 2008; 66:590-598; PMID:19049654; http://dx.doi.org/10.1111/j.1574-6941.2008.00609.x
   PubMedGoogle Scholar
• Fiehn O, Wohlgemuth G, Scholz M. Setup and annotation of metabolomic experiments by integrating biological and mass spectrometric metadata. Data Integr life Sci 2005;224-39; http://dx.doi.org/10.1007/11530084_18
   Google Scholar
• Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 2013; 9:280-99; PMID:23543913; http://dx.doi.org/10.1007/s11306-012-0482-9
   PubMed Web of Science ®Google Scholar
• Barupal DK, Haldiya PK, Wohlgemuth G, Kind T, Kothari SL, Pinkerton KE, Fiehn O. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics 2012; 13:99; PMID:22591066; http://dx.doi.org/10.1186/1471-2105-13-99
   PubMed Web of Science ®Google Scholar
• Kabeerdoss J, Sankaran V, Pugazhendhi S, Ramakrishna BS. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India. BMC Gastroenterol 2013; 13:20; PMID:23351032; http://dx.doi.org/10.1186/1471-230X-13-20
   PubMed Web of Science ®Google Scholar
• Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJO. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006; 44:4136-41; PMID:16988016; http://dx.doi.org/10.1128/JCM.01004-06
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-11; PMID:16188921; http://dx.doi.org/10.1136/gut.2005.073817
   PubMed Web of Science ®Google Scholar
• Frank DN, St Amand AL, Feldman R a, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-5; PMID:17699621; http://dx.doi.org/10.1073/pnas.0706625104
   PubMed Web of Science ®Google Scholar
• De la Fuente M, Franchi L, Araya D, Díaz-Jiménez D, Olivares M, Alvarez-Lobos M, Golenbock D, González M-J, López-Kostner F, Quera R, et al. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol 2014; :1-9; PMID:24183099; http://dx.doi.org/10.1155/2014/489569
   PubMedGoogle Scholar
• Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56:669-75; PMID:17028128; http://dx.doi.org/10.1136/gut.2006.099796
   PubMed Web of Science ®Google Scholar
• Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaessig S, McDonough PL, German AJ, Yates RM, Russell DG, Johnson SE, et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 2006; 74:4778-92; PMID:16861666; http://dx.doi.org/10.1128/IAI.00067-06
   PubMed Web of Science ®Google Scholar
• Suchodolski JS, Camacho J, Steiner JM. Analysis of bacterial diversity in the canine duodenum, jejunum, ileum, and colon by comparative 16S rRNA gene analysis. FEMS Microbiol Ecol 2008; 66:567-78; PMID:18557939; http://dx.doi.org/10.1111/j.1574-6941.2008.00521.x
   PubMed Web of Science ®Google Scholar
• Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner JM, Cohen ND, Jergens AE, Suchodolski JS. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS One 2014; 9:e94699; PMID:24722235; http://dx.doi.org/10.1371/journal.pone.0094699
   PubMed Web of Science ®Google Scholar
• Blachier F, Mariotti F, Huneau JF, Tomé D. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 2007; 33:547-62; PMID:17146590; http://dx.doi.org/10.1007/s00726-006-0477-9
   PubMed Web of Science ®Google Scholar
• Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, Kau AL, Rich SS, Concannon P, Mychaleckyj JC, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339:548-54; PMID:23363771; http://dx.doi.org/10.1126/science.1229000
   PubMed Web of Science ®Google Scholar
• Duncan SH, Hold GL, Harmsen HJM, Stewart CS, Flint HJ. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol 2002; 52:2141-6; http://dx.doi.org/10.1099/ijs.0.02241-0
   PubMed Web of Science ®Google Scholar
• Garcia-Mazcorro JF, Dowd SE, Poulsen J, Steiner JM, Suchodolski JS. Abundance and short-term temporal variability of fecal microbiota in healthy dogs. Microbiologyopen 2012;1:340-7; PMID:23170232; http://dx.doi.org/10.1002/mbo3.36
   PubMed Web of Science ®Google Scholar
• Riganti C, Gazzano E, Polimeni M, Aldieri E, Ghigo D. The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic Biol Med 2012; 53:421-36; PMID:22580150; http://dx.doi.org/10.1016/j.freeradbiomed.2012.05.006
   PubMed Web of Science ®Google Scholar
• Bertin Y, Girardeau JP, Chaucheyras-Durand F, Lyan B, Pujos-Guillot E, Harel J, Martin C. Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. Environ Microbiol 2011; 13:365-77; PMID:20849446; http://dx.doi.org/10.1111/j.1462-2920.2010.02334.x
   PubMed Web of Science ®Google Scholar
• Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward D V, Reyes J a, Shah S a, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13:R79; PMID:23013615; http://dx.doi.org/10.1186/gb-2012-13-9-r79
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson L a, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15:382-92; PMID:24629344; http://dx.doi.org/10.1016/j.chom.2014.02.005
   PubMed Web of Science ®Google Scholar
• Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M, Gallini CA, Beal C, van Hylckama-Vlieg JE, Ballal S a, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J 2014; 1-15; PMID:24152717
   PubMedGoogle Scholar
• Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F. Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 2005; 55:38-44; PMID:15574479; http://dx.doi.org/10.1093/jac/dkh495
   PubMed Web of Science ®Google Scholar
• Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Z Li J, Young VB. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 2014; 5:3114; PMID:24445449; http://dx.doi.org/10.1038/ncomms4114
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. correspondEnce QIIME allows analysis of high- throughput community sequencing data Intensity normalization improves color calling in SOLiD sequencing. Nat Publ Gr 2010; 7:335-6
   Google Scholar
• Garcia-Mazcorro JF, Suchodolski JS, Jones KR, Clark-Price SC, Dowd SE, Minamoto Y, Markel M, Steiner JM, Dossin O. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs. Fems Micriobiology Ecol 2012; 80:642-636
   Google Scholar
• Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 2010; 5:e15234; PMID:21170321; http://dx.doi.org/10.1371/journal.pone.0015234
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60; PMID:21702898; http://dx.doi.org/10.1186/gb-2011-12-6-r60
   PubMed Web of Science ®Google Scholar
• Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 2011; 6:743-60; PMID:21637195; http://dx.doi.org/10.1038/nprot.2011.319
   PubMed Web of Science ®Google Scholar
• Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P, Lotia S, Pico AR, Bader GD, Ideker T. A travel guide to Cytoscape plugins. 2012; 9:1069-76; PMID:23132118
   PubMedGoogle Scholar